BioNeutra Global Corporation
BGA.V
TSX
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -5.54% | -97.52% | -847.21% | -72.71% | -55.90% |
| Total Depreciation and Amortization | 0.49% | -16.49% | -11.77% | -62.57% | -4.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -7.16% | -- |
| Total Other Non-Cash Items | -24.89% | -94.31% | 28.89% | 30.85% | 122.54% |
| Change in Net Operating Assets | 229.36% | 177.10% | -15.04% | 285.86% | 21.77% |
| Cash from Operations | 183.89% | 79.44% | -76.70% | 311.61% | -238.07% |
| Capital Expenditure | 94.46% | 85.61% | 95.11% | 166.46% | -337.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 95.71% | -- | -- | -- | -- |
| Cash from Investing | 95.21% | 89.76% | 96.71% | 166.46% | -690.91% |
| Total Debt Issued | -41.30% | -- | -- | -24.35% | -- |
| Total Debt Repaid | -290.54% | 83.04% | 29.92% | -14.56% | 126.81% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.14% | -99.79% | -54.80% | -97.05% | -575.46% |
| Cash from Financing | 600.78% | -190.75% | 5.41% | -294.75% | 111.92% |
| Foreign Exchange rate Adjustments | -239.63% | -34.26% | -685.00% | -243.42% | -60.68% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 223.44% | 87.63% | -112.09% | 37.04% | -626.98% |
